Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2021

1 Short Bowel Syndrome (SBS) Drugs Market Overview

• 1.1 Product Overview and Scope of Short Bowel Syndrome (SBS) Drugs
• 1.2 Short Bowel Syndrome (SBS) Drugs Segment by Type
  • 1.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Glucagon-Like Peptide-2 (GLP-2)
  • 1.2.3 Growth Hormone
  • 1.2.4 Glutamine
  • 1.2.5 Other
• 1.3 Short Bowel Syndrome (SBS) Drugs Segment by Application
  • 1.3.1 Short Bowel Syndrome (SBS) Drugs Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Retail Pharmacies
• 1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue 2016-2027
  • 1.4.2 Global Short Bowel Syndrome (SBS) Drugs Sales 2016-2027
  • 1.4.3 Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Short Bowel Syndrome (SBS) Drugs Market Competition by Manufacturers

• 2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Short Bowel Syndrome (SBS) Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Short Bowel Syndrome (SBS) Drugs Market Competitive Situation and Trends
  • 2.5.1 Short Bowel Syndrome (SBS) Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Short Bowel Syndrome (SBS) Drugs Players Market Share by Revenue
  • 2.5.3 Global Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario by Region

• 3.1 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
  • 3.3.1 North America Short Bowel Syndrome (SBS) Drugs Sales by Country
  • 3.3.2 North America Short Bowel Syndrome (SBS) Drugs Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country
  • 3.4.2 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region
  • 3.5.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country
  • 3.6.2 Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country
  • 3.7.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Type

• 4.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2016-2021)

5 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Application

• 5.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2016-2021)
• 5.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2016-2021)
• 5.3 Global Short Bowel Syndrome (SBS) Drugs Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Merck
  • 6.1.1 Merck Corporation Information
  • 6.1.2 Merck Description and Business Overview
  • 6.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Merck Product Portfolio
  • 6.1.5 Merck Recent Developments/Updates
• 6.2 Takeda
  • 6.2.1 Takeda Corporation Information
  • 6.2.2 Takeda Description and Business Overview
  • 6.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Takeda Product Portfolio
  • 6.2.5 Takeda Recent Developments/Updates
• 6.3 Emmaus Medical
  • 6.3.1 Emmaus Medical Corporation Information
  • 6.3.2 Emmaus Medical Description and Business Overview
  • 6.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Emmaus Medical Product Portfolio
  • 6.3.5 Emmaus Medical Recent Developments/Updates
• 6.4 Ardelyx
  • 6.4.1 Ardelyx Corporation Information
  • 6.4.2 Ardelyx Description and Business Overview
  • 6.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Ardelyx Product Portfolio
  • 6.4.5 Ardelyx Recent Developments/Updates
• 6.5 Naia Pharmaceuticals
  • 6.5.1 Naia Pharmaceuticals Corporation Information
  • 6.5.2 Naia Pharmaceuticals Description and Business Overview
  • 6.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Naia Pharmaceuticals Product Portfolio
  • 6.5.5 Naia Pharmaceuticals Recent Developments/Updates
• 6.6 Nutrinia
  • 6.6.1 Nutrinia Corporation Information
  • 6.6.2 Nutrinia Description and Business Overview
  • 6.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Nutrinia Product Portfolio
  • 6.6.5 Nutrinia Recent Developments/Updates
• 6.7 OxThera
  • 6.6.1 OxThera Corporation Information
  • 6.6.2 OxThera Description and Business Overview
  • 6.6.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 OxThera Product Portfolio
  • 6.7.5 OxThera Recent Developments/Updates
• 6.8 Sancilio Pharmaceuticals
  • 6.8.1 Sancilio Pharmaceuticals Corporation Information
  • 6.8.2 Sancilio Pharmaceuticals Description and Business Overview
  • 6.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Sancilio Pharmaceuticals Product Portfolio
  • 6.8.5 Sancilio Pharmaceuticals Recent Developments/Updates
• 6.9 Zealand Pharma
  • 6.9.1 Zealand Pharma Corporation Information
  • 6.9.2 Zealand Pharma Description and Business Overview
  • 6.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Zealand Pharma Product Portfolio
  • 6.9.5 Zealand Pharma Recent Developments/Updates

7 Short Bowel Syndrome (SBS) Drugs Manufacturing Cost Analysis

• 7.1 Short Bowel Syndrome (SBS) Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
• 7.4 Short Bowel Syndrome (SBS) Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Short Bowel Syndrome (SBS) Drugs Distributors List
• 8.3 Short Bowel Syndrome (SBS) Drugs Customers

9 Short Bowel Syndrome (SBS) Drugs Market Dynamics

• 9.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
• 9.2 Short Bowel Syndrome (SBS) Drugs Growth Drivers
• 9.3 Short Bowel Syndrome (SBS) Drugs Market Challenges
• 9.4 Short Bowel Syndrome (SBS) Drugs Market Restraints

10 Global Market Forecast

• 10.1 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Type (2022-2027)
• 10.2 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Application (2022-2027)
• 10.3 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List